Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: results of a single-centre randomized phase 3 trial

in: BMC Cancer | 2011

von Rinaldo Massimo | Thomas Renato | D'Aiuto Giuseppe | +16

Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trial

in: BMC Cancer | 2007

von Staiano Maria | La Vecchia Franca | Formichelli Franca | +20

Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial

in: BMC Cancer | 2006

von D'Arco Alfonso | Musso Pietro | Ferro Antonella | +17

Tamoxifen is not effective in good prognosis patients with hepatocellular carcinoma

in: BMC Cancer | 2006

von Daniele Bruno | Signoriello Giuseppe | Di Maio Massimo | +5

Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study

in: BMC Cancer | 2006

von Danese Saverio | Nardi Mario | Cartenì Giacomo | +17

Compliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experience

in: BMC Cancer | 2005

von Rinaldo Massimo | Capasso Immacolata | D'Aiuto Giuseppe | +13